Andrew W. Horne

ORCID: 0000-0002-9656-493X · 205 papers in corpus
2026
PloS one ·doi:10.1371/journal.pone.0350169

Chronic visceral pain affects over 20% of adults globally but remains poorly understood, significantly impacting quality of life and healthcare costs. Limited understanding and diagnostic misconceptions hinder effective management, particul…

article 2026
Reproduction & fertility ·doi:10.1530/raf-25-0127

ABSTRACT: Endometriosis is a common, inflammatory condition impacting 200 million women and those assigned female at birth, where 25-40% experience infertility. Ovarian endometriosis is known to decrease anti-Müllerian hormone (AMH) levels …

other 2026
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.70113
peer-review 2026
·doi:10.1530/raf-26-0130
other 2026
Reproduction & fertility ·doi:10.1530/RAF-26-0130
rct 2026
BMJ open ·doi:10.1136/bmjopen-2026-116964

INTRODUCTION: Treatment for women with endometriosis is only partially or temporarily effective. Moreover, medical hormonal treatment is associated with debilitating side effects and interferes with fertility, while surgery has a relatively…

rct 2026
Reproduction & fertility ·doi:10.1530/raf-26-0043

Endometriosis is a chronic pain condition that affects >190 million people worldwide. It is recommended in clinical guidelines to remove the most common type of endometriosis, 'superficial peritoneal endometriosis' (SPE), if it is diagnosed…

preprint 2026
·doi:10.64898/2026.08.26.26361442

Background: Endometriosis is a chronic pain condition in which hormonal therapies form the cornerstone of long-term management. Treatment tolerability is critical for adherence and therapeutic success, but most comparative studies and revi…

other 2026
Human reproduction open ·doi:10.1093/hropen/hoag030

STUDY QUESTION: Was the efficacy of linzagolix, observed at 6 months in women with endometriosis-associated pain, maintained when administered for an additional 6 months? SUMMARY ANSWER: Efficacy from this extension study complements the r…

other 2026
Pain ·doi:10.1097/j.pain.0000000000003916
review 2026
Reproduction & fertility ·doi:10.1530/raf-26-0075

ABSTRACT: In women with uterine adenomyosis, bleeding and pain can have a major impact on quality of life. There is clearly a widespread demand for effective long-term medical therapies. The objective of this narrative review was to investi…

article 2026
article 2026
European journal of endocrinology ·doi:10.1093/ejendo/lvag109

OBJECTIVE: Endometriosis is a chronic, hormone-dependent condition affecting an estimated 190 million women worldwide. Our understanding of hormonal contributions to endometriosis pathophysiology is incomplete, hindering the identification …

other 2026
Reproduction & fertility ·doi:10.1530/RAF-25-0091

ABSTRACT: We explore bladder sensitivity profiles in females with chronic pelvic pain, using a non-invasive bladder sensitivity paradigm. We aim to determine how profiles differ between groups defined by symptoms; groups defined by diagnose…

other 2026
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.09.032

OBJECTIVE: To determine the future priorities for ectopic pregnancy research. DESIGN: Potential research questions were collated from an initial international survey, a systematic review of clinical practice guidelines, and Cochrane system…

other 2026
Pain ·doi:10.1097/j.pain.0000000000003857

Chronic pelvic pain (CPP) is a common and burdensome symptom in women yet current clinical management frequently leaves many with persistent pain. The Translational Research in Pelvic Pain (TRiPP) project adopts a pain-focused strategy, aim…

preprint 2025
·doi:10.1101/2025.08.25.25334349

Abstract Study question How are the levels of anti-Müllerian hormone and inflammatory cytokines influenced by superficial peritoneal endometriosis (SPE)? Summary answer Fertility metrics (Endometriosis Fertility Index (EFI), and serum anti-…

article 2025
·doi:10.1016/j.lanogw.2025.100004
article 2025
·doi:10.1080/23293691.2025.2540344

Endometriosis affects approximately 10% of women of reproductive age worldwide. Journeys to diagnosis can be complex, with an average of 9 years between development of symptoms and diagnosis, which has not improved despite guidance and poli…

other 2025
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.18066

OBJECTIVE: To build consensus on most important symptoms and related consequences for use in questionnaires to characterise individuals with suspected and confirmed endometriosis in the general population. DESIGN: A questionnaire of 107 sy…

other 2025
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.113953
other 2025
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.18245
other 2025
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70522

The goal was to develop a pragmatic classification system for conditions associated with chronic pelvic pain (CPP), aiming to enhance diagnosis, management, education, and research of CPP. An international, multidisciplinary panel participa…

article 2025
·doi:10.1016/j.lanogw.2025.100028
article 2025
JAMA network open ·doi:10.1001/jamanetworkopen.2025.3152

This survey study examines which dietary modifications or supplements were perceived as beneficial for pain management by individuals with endometriosis.